Table 3 Review of radiotherapy studies on orbital lymphoma.
From: Radiation therapy in primary orbital lymphoma: a single institution retrospective analysis
Series | N° of patients | Stage | Histology | Dose (Gy) | Local control | Survival at 5 years |
|---|---|---|---|---|---|---|
Jereb et al.[3] | 19 | I, II and IV | Low and intermediate | 20-37.5 | 100% | NA |
Smitt et al.[9] | 25 | I-II | Low, intermediate and high | 28-40.2 | 89% | 93% |
Chao et al.[10] | 20 | I | Low and intermediate | 20-43.2 | 100% | 90% |
Bolek et al[11] | 20 | I-II | Low, intermediate and high | 15-53.3 | 95% | Low 89%, interm and high 33% |
Stafford et al[13] | 48 | I-II | Low, intermediate and high | 15-53.8 | 98% | 88% |
Liao et al.[32] | 25 | I | Low and intermediate | 30-40 | 100% | NA |
Bhatia et al.[15] | 47 | I | Low, intermediate and high | 20-51 | 100% | 74% |
Martinet et al.[18] | 90 | I-II | Low, intermediate and high | 4.0-50.4 | 97% | 78% |
Fung et al. [6] | 98 | I and III-IV | MALT, Follicular DLBCL | 16.2-46 | 98% | Stage I,94% III-IV, 49% |
Zhou et al. [20] | 46 | I-IV | Low, intermediate and high | 30.6 | 98% | 88% |
Aviles et al.[33] | 98 | IE | MALT | 34-40 | 98% | 96% |
Bischof et al. [21] | 42 | I-IV | Low, intermediate and high | 20-46 | 80-100% | Stage I, 91% II, 80% III-IV, 47% |
Nam H et al.[34] | 66 | I | MALT | 20-45 | 97% | NA |
Son SH [35] | 46 | IE | MALT | 21.6-45 | 98% | 100% |